BD (NYSE:BDX) filed a lawsuit in a U.S. District Court alleging patent infringement by Baxter (NYSE:BAX) related to infusion ...

Glucotrack (Nasdaq:GCTK) announced today that it received a hospital's ethical approval to study its continuous blood glucose ...

Dexcom (Nasdaq:DXCM) announced today that it promoted Jake Leach to the role of president, in addition to his post as COO.

Roche announced today that it plans to invest up to $550 million to expand its continuous glucose monitoring (CGM) site in ...

Embecta now expects revenues between $1.073 billion and $1.09 billion. This would mark a sales dip of between 4.4% and 2.9% ...

Phillips Medisize announced that it officially integrated Vectura into its business, expanding its capabilities in inhaled ...

(NYSE:SENS) shares dipped after hours today on first-quarter results that beat revenue projections on Wall Street.

Tandem Diabetes Care shared that its Capillary Biomedical (CapBio) subsidiary won FDA 510(k) clearance for a new infusion set.

Insulet recorded a 31.3% bottom-line slide on a sales increase of 28.8%. Adjusted to exclude one-time items, earnings per ...

A mission to outer space includes plans to utilize modern diabetes management technology to assess its viability in ...